Adjuvant surgery for advanced extrahepatic cholangiocarcinoma

9Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Patients with Stage IV cholangiocarcinoma are currently not considered to be surgical candidates and are typically offered systemic chemotherapy. Recently, several novel systemic chemotherapy regimens have allowed an initially unresectable cholangiocarcinoma to be resectable. The aim of this article is to present the usefulness of adjuvant surgery in a case of advanced cholangiocarcinoma that was successfully treated with gemcitabine. A 72-year-old man was diagnosed with distal cholangiocarcinoma with liver metastases (cT2N0M1, Stage IV). He underwent metal stent placement in the duodenum to alleviate jaundice. After 18 courses of chemotherapy using gemcitabine without severe drug toxicities, a computed tomography scan showed that the liver metastases in S6 and S7 had disappeared. The patient underwent subtotal stomachpreserving pancreaticoduodenectomy and lymph node dissection. The pathological stage was pT2N0M0, Stage I B. The patient underwent 6 cycles of adjuvant chemotherapy using gemcitabine. The patient is alive and well 6 years and 9 mo after the diagnosis. © 2013 Baishideng. All rights reserved.

Cite

CITATION STYLE

APA

Oshiro, Y., Takahashi, K., Sasaki, R., Kondo, T., Sakashita, S., & Ohkohchi, N. (2013). Adjuvant surgery for advanced extrahepatic cholangiocarcinoma. World Journal of Gastroenterology, 19(40), 6934–6938. https://doi.org/10.3748/wjg.v19.i40.6934

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free